Skip to main content
Top
Literature
1.
go back to reference Quintana-Díaz M, Muñoz-Romo R, Gómez-Ramírez S, Pavía J, Borobia AM, García-Erce JA, Muñoz M (2017) A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia. Blood Transfus 15:438–446PubMedPubMedCentral Quintana-Díaz M, Muñoz-Romo R, Gómez-Ramírez S, Pavía J, Borobia AM, García-Erce JA, Muñoz M (2017) A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia. Blood Transfus 15:438–446PubMedPubMedCentral
2.
go back to reference Girelli D, Marchi G, Busti F (2017) Iron replacement therapy: entering the new era without misconceptions, but more research needed. Blood Transfus 15:379–381PubMedPubMedCentral Girelli D, Marchi G, Busti F (2017) Iron replacement therapy: entering the new era without misconceptions, but more research needed. Blood Transfus 15:379–381PubMedPubMedCentral
3.
go back to reference Bilbao J (2006) AnemiascarencialesI anemia feropenica. Información Terapéutica del Sistema Nacional de Salud 30:35–41 Bilbao J (2006) AnemiascarencialesI anemia feropenica. Información Terapéutica del Sistema Nacional de Salud 30:35–41
4.
go back to reference India Fact Sheet: National Family and Health Survey-4(NFHS-4) 2015-2016. Fact sheet National Data page-6. International Institute of Population Science, Mumbai, India. Ministry of Health and family Welfare Govt of India. New Delhi, India India Fact Sheet: National Family and Health Survey-4(NFHS-4) 2015-2016. Fact sheet National Data page-6. International Institute of Population Science, Mumbai, India. Ministry of Health and family Welfare Govt of India. New Delhi, India
5.
go back to reference Ghosh K (2006) Non haematological effects of iron deficiency—a perspective. Indian J Med Sci 60:30–37CrossRefPubMed Ghosh K (2006) Non haematological effects of iron deficiency—a perspective. Indian J Med Sci 60:30–37CrossRefPubMed
9.
go back to reference Gorakshkar AC, Ghosh K (2012) Subclinical iron deficiency is a silent epidemic amongst voluntary blood donors. Transfus Med 22:300–301CrossRefPubMed Gorakshkar AC, Ghosh K (2012) Subclinical iron deficiency is a silent epidemic amongst voluntary blood donors. Transfus Med 22:300–301CrossRefPubMed
10.
go back to reference Dara RC, Marwaha N, Khetan D, Patidar GK (2016) A randomized control study to evaluate effects of short-term oral ironsupplementation in regular voluntary blood donors. Indian J Hematol Blood Transfus 32:299–306CrossRefPubMed Dara RC, Marwaha N, Khetan D, Patidar GK (2016) A randomized control study to evaluate effects of short-term oral ironsupplementation in regular voluntary blood donors. Indian J Hematol Blood Transfus 32:299–306CrossRefPubMed
11.
go back to reference Camaschella C (2015) Iron deficiency: new insights into diagnosis and treatment. Hematol Am Soc Hematol Educ Progr 2015:8–13 Camaschella C (2015) Iron deficiency: new insights into diagnosis and treatment. Hematol Am Soc Hematol Educ Progr 2015:8–13
12.
go back to reference Bager P, Hvas CL, Dahlerup JF (2017) Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions. Br J Clin Pharmacol 83(5):1118–1125CrossRefPubMed Bager P, Hvas CL, Dahlerup JF (2017) Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions. Br J Clin Pharmacol 83(5):1118–1125CrossRefPubMed
Metadata
Title
Fast Track Anaemia Clinic (FTAC) and Intravenous Iron Administration: Its Relevance and Application Today in India
Author
Kanjaksha Ghosh
Publication date
01-04-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0878-9

Other articles of this Issue 2/2018

Indian Journal of Hematology and Blood Transfusion 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine